SBMT is the scientific society. WBMF is the charitable foundation. BTIP is the innovation bridge.
Together, these three pathways form one ecosystem for brain health impact, but each has a distinct role. SBMT advances the science and professional community, WBMF supports charitable and mission-driven programs, and BTIP helps move validated neurotechnology discoveries toward real-world patient solutions.
Who is SBMT?
The Society for Brain Mapping and Therapeutics is a multidisciplinary and multi-specialty professional association founded in 2004 to fast-track therapeutics for neurological disorders.
SBMT convenes neurosurgeons, physicians, scientists, engineers, entrepreneurs, philanthropists, venture capitalists, policymakers, patient advocacy groups, journals, conferences, and a global scientific community focused on advancing brain mapping, neurotechnology, and therapeutic innovation.
- Brings together the scientific, clinical, engineering, policy, and industry communities.
- Advances brain mapping, neurotechnology, diagnostics, and therapeutics for neurological disorders.
- Organizes scientific programs, conferences, policy engagements, publications, and global collaborations.
- Helps translate research knowledge into clinical, educational, and policy action.
Where does BTIP fit?
The Brain Technology and Innovation Park is a joint initiative of WBMF and SBMT focused on innovation, translation, integration, commercialization, and democratization of neurotechnology. BTIP brings together venture capital, private equity, angel funds, impact funds, hedge funds, philanthropic investment, and SBMT’s global network of scientists, engineers, physicians, surgeons, and entrepreneurs to help introduce next-generation diagnostics and therapeutics.
SBMT · WBMF · BTIP
Where breakthroughs come to life through innovation, venture, and philanthropy.
The Society for Brain Mapping and Therapeutics and the World Brain Mapping Foundation connect science, medicine, policy, philanthropy, and commercialization to detect neurological disorders earlier and create the next generation of diagnostics and therapeutics.
SBMT is a 501(c)(6) professional society. WBMF is a 501(c)(3) public charity. BTIP is a joint innovation initiative connecting discovery, venture-philanthropy, commercialization, and patient impact.
The simplest way to understand us
We are not only mapping the brain. We are turning brain mapping into diagnostics, therapeutics, and access.
This ecosystem brings together physicians, neurosurgeons, engineers, researchers, policymakers, venture capitalists, philanthropists, patient advocates, and industry leaders to fast-track therapeutics for neurological disorders.
Discover
SBMT convenes the scientific, clinical, engineering, industry, journal, conference, policy, and global research community.
Fund
WBMF supports mission-driven brain health programs, humanitarian access, education, veterans, women in neurotech, and young investigators.
Build
BTIP helps validated discoveries move toward devices, therapies, companies, venture-philanthropy, and real-world patient impact.
Three engines, one ecosystem
Science through SBMT. Philanthropy through WBMF. Innovation through BTIP.
Each entity has a different legal role, but together they create a coordinated pathway from research discovery to clinical adoption and patient access.
SBMT: Scientific Engine
SBMT is a multidisciplinary and multi-specialty professional society founded in 2004. It convenes surgeons, physicians, scientists, engineers, industry leaders, policymakers, philanthropists, venture leaders, patient advocacy groups, journals, conferences, and a global scientific community to advance brain mapping, neurotechnology, and therapeutics.
DiscoverWBMF: Philanthropic Engine
WBMF funds the discoveries, people, patients, and global access programs that make brain health innovation possible, including veterans, humanitarian missions, fellows, women in neurotech, kids education, and public-benefit initiatives.
FundBTIP: Commercialization Engine
The Brain Technology and Innovation Park focuses on innovation, translation, integration, commercialization, and democratization of neurotechnology through venture-philanthropy, connecting capital partners with SBMT’s global network of engineers, entrepreneurs, surgeons, physicians, and scientists.
BuildYour generous donation supports
Programs that move brain health innovation toward people who need it.
Donations through WBMF support public-benefit initiatives and may be tax-deductible to the extent allowed by law.
Veterans Neurotech Initiative
Introducing advanced therapeutics and neurotechnology for wounded soldiers and veterans.
Women in Neurotech Group
Training and elevating the next generation of female scientists, clinicians, innovators, and entrepreneurs.
National Center for NanoBioElectronics
Integrating AI Tech, NanoTech, CellTech, PharmaTech, and MedTech to introduce next-generation therapeutics.
BTIP
Accelerating validated neurotechnology discoveries toward devices, companies, commercialization, and patient impact.
Kateb Scholars Program
Training undergraduate, graduate, postdoctoral, and professional leaders to become science organizers, scholars, innovators, entrepreneurs, and policymakers.
Annual Neurotech Convention
Bringing pioneering surgeons, scientists, technologists, industry leaders, government officials, and Nobel laureates together.
Global Physicians and Scientists
Humanitarian medical support for crisis regions, including earthquake response, PPE support, and support for doctors and surgeons in Ukraine.
Kids Corner
Helping K-12 students understand their brain potential, wellness, and future pathways in neuroscience and brain health.
Policy, legislation, and global brain health
SBMT carries brain, spine, mental health, and neurotechnology into policy rooms.
SBMT’s policy engagement connects scientists and clinicians with lawmakers, governments, and global policy platforms so brain health innovation can move beyond the laboratory.
The commercialization bridge
BTIP helps make SBMT one of the world’s largest neurotech ecosystems.
BTIP brings together venture capital, private equity funds, angel funds, impact funds, hedge funds, philanthropic investments, and SBMT’s 100,000+ global network of engineers, entrepreneurs, surgeons, physicians, and scientists to introduce next-generation diagnostics and therapeutics.
Choose your pathway
Join the ecosystem where brain science becomes real-world solutions.
For scientists, physicians, and trainees
Join SBMT to collaborate, publish, present, mentor, and participate in the global brain mapping and therapeutics community.
Become a MemberFor donors and philanthropists
Support WBMF initiatives that fund veterans, humanitarian care, young investigators, women in neurotech, kids education, and global access.
Donate to WBMFFor industry, startups, and investors
Partner with SBMT and BTIP through neurotechnology events, innovation programs, sponsorships, startup pathways, and commercialization opportunities.
Partner with UsTwo global stages for the future of brain health innovation.
The Society for Brain Mapping and Therapeutics brings together the scientific, clinical, policy, investment, and neurotechnology communities through two major flagship events: Neuroscience20 and the 24th Annual Neurotech Event.
Neuroscience20 and N20 Miami 2026
Neuroscience20 is SBMT’s global policy platform aligned with the G20, advancing brain, spine, and mental health as international scientific, clinical, and economic priorities.
The 2026 N20 Miami event brings together policy leaders, scientists, physicians, innovators, and global stakeholders to accelerate brain health policy, neurotechnology adoption, and patient-centered impact.
24th Annual Neurotech Event 2027
SBMT’s Annual Neurotech Event is the flagship gathering for brain mapping, neurotechnology, therapeutics, AI, imaging, neurosurgery, policy, commercialization, and translational medicine.
The 2027 event brings together pioneering surgeons, scientists, technologists, industry leaders, government officials, investors, patient advocates, and global neuroscience leaders.
From the G20 stage to a global brain health movement.
Neuroscience20 has created a recurring international platform for brain, spine, and mental health policy. The global map highlights where N20 has taken place so far and shows how SBMT continues to connect science, policy, innovation, and patient impact across regions.
Scientific excellence, clinical leadership, and visionary service.
SBMT is privileged to be guided by leaders whose work spans neuroscience, surgery, molecular medicine, memory research, synaptic biology, innovation, education, and global health impact. This section highlights our latest President and two Nobel Laureate leaders, while inviting visitors to explore the full depth of our Board of Directors and leadership team.
We are deeply grateful for the leaders who stand with SBMT.
Their presence on our team and board strengthens SBMT’s credibility, expands our scientific reach, and reminds our global community that brain mapping and therapeutics require both world-class discovery and compassionate clinical leadership.
Stefano M. Sinicropi, MD
24th President of SBMT • President and CEO, Midwest Spine & Brain Institute • Board-Certified Spine Surgeon • Founder, Hypercharge Health
Dr. Stefano M. Sinicropi brings SBMT a powerful combination of clinical excellence, organizational leadership, surgical experience, and forward-looking interest in regenerative and longevity medicine. As President and CEO of Midwest Spine & Brain Institute, he leads a comprehensive orthopedic and neurosurgical spine practice serving patients across Minnesota and the Midwest.
His career reflects both patient-centered medicine and system-building. After completing the Kenton D. Leatherman spine fellowship at the University of Louisville, he helped grow Midwest Spine into Midwest Spine & Brain Institute, expanded clinical sites, recruited talented surgeons and providers, and built partnerships across hospital systems throughout Minnesota and Western Wisconsin.
We are honored to have Dr. Sinicropi serving as SBMT’s 24th President. His background in minimally invasive spine surgery, disc replacement, complex spine care, regenerative health, keynote speaking, and healthcare leadership adds meaningful strength to SBMT’s mission of advancing brain, spine, and mental health innovation.
Two Nobel Laureates helping elevate SBMT’s scientific mission.
SBMT is especially privileged to have Nobel Laureate leaders whose discoveries helped define modern neuroscience. Their work has shaped how the world understands memory, synaptic plasticity, neurotransmission, vesicle traffic, and the molecular machinery of communication between cells.
Thomas C. Südhof
Nobel Prize in Physiology or Medicine, 2013 • Professor of Molecular and Cellular Physiology, Stanford University School of Medicine
Dr. Thomas C. Südhof received the 2013 Nobel Prize in Physiology or Medicine for discoveries related to the machinery regulating vesicle traffic, a major transport system in cells. His work in neuroscience revealed how synaptic vesicles are positioned and controlled so neurons can release signal-bearing molecules at precisely the right moment.
His research helped explain calcium-regulated neurotransmitter release and presynaptic mechanisms that are central to how neurons communicate. This work continues to influence research in synaptic biology, neurodevelopmental disorders, neurodegeneration, and the molecular foundations of brain function.
Eric R. Kandel
Nobel Prize in Physiology or Medicine, 2000 • Columbia University • Foundational leader in the cellular and molecular biology of learning and memory
Dr. Eric R. Kandel received the 2000 Nobel Prize in Physiology or Medicine for discoveries concerning signal transduction in the nervous system. His research used the sea slug Aplysia to reveal molecular mechanisms involved in learning and memory, including how synaptic strength can be modified.
His work helped establish that learning can produce lasting changes in behavior by changing the strength of connections between nerve cells. Through his decades of leadership at Columbia University and the Kavli Institute for Brain Science, Dr. Kandel’s contributions continue to shape memory research, psychiatry, molecular neuroscience, and the broader understanding of brain function.
The future of brain health will not build itself.
It will be built by scientists, physicians, engineers, innovators, donors, policymakers, patient advocates, and communities who believe that neurological disorders deserve faster, smarter, and more compassionate solutions.
Through SBMT, WBMF, and BTIP, we are creating a connected ecosystem where science is convened, philanthropy is activated, and innovation is moved toward real-world patient impact. Whether you join as a member, support the foundation, sponsor a flagship event, or help advance one of our initiatives, your participation helps move brain mapping, neurotechnology, and therapeutics from possibility to practice.
The World Brain Mapping Foundation is the 501(c)(3) charitable foundation pathway for donations. The Society for Brain Mapping and Therapeutics is the 501(c)(6) professional society pathway for membership, scientific convening, education, and professional collaboration.